Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered under Fed Conditions in Healthy Chinese Volunteers
Phase of Trial: Phase I
Latest Information Update: 23 Dec 2016
At a glance
- Drugs Aramchol (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Galmed Pharmaceuticals
- 20 Dec 2016 Status changed from recruiting to completed.
- 11 Jun 2016 New trial record
- 07 Jun 2016 The results of Part A of this study are expected to be available in August 2016, according to a Galmed Pharmaceuticals media release.